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CLINICAL INVESTIGATION
Lack of glomerular hemodynamic stimulation after infusion of
branched-chain amino acids
ALDO CLARIS-APPIANI, BAROUKH M. ASSAEL, AMEDEA S. TIRELLI, GIUSEPPINA MARRA,
and GRAZIELLA CAVANNA
Clinica Pediatrica ii, University of Milan, Milan, italy
Lack of glomerular hemodynamic stimulation after infusion of branched-
chain amino acids. Renal hemodynamics (mutest. CPAH) were studied
in five adult volunteers infused on separate occasions with branched-
chain amino acids (BCAA), a mixture of nonessential and essential
amino acids of the same volume, osmolality and nitrogen content, and
0.9% saline solution. BCAA infusion caused moderate renal vasocon-
striction, a slight increase of GFR and a progressive rise of the filtration
fraction (FF), whereas the amino acids mixture induced a significantly
higher increase of GFR and a state of renal vasodilatation without
altering the FF. The volume expansion with 0.9% saline did not cause
any notable hemodynamic modification except for reduced FF. This
study demonstrates that whereas a state of hyperfiltration and hypere-
mia is specifically induced by an amino acid mixture independently of
volume expansion and osmolar load, the administration of BCAA
provides nitrogen without renal hemodynamic stimulation.
Various studies have been performed on the effect of a
protein or amino acid load on glomerular filtration rate (GFR)
and renal plasma flow (RPF) [1—4], but very few have reported
the possible differences in the effects that single amino acids or
single classes of amino acids have on renal function. Hyperfil-
tration and renal vasodilatation have been observed with the
infusion of glycine alone [5] and arginine alone [6]. Lee and
Summerill [7] tested oral loads of glycine, serine, alanine,
threonine, proline, glutamic acid, aspartic acid and valine
administered singly to the dog, but did not find any one amino
acid more effective than any other in increasing GFR. The
interest of studies on the influence on renal function of essential
amino acids (EAA) and particularly of the branched-chain
amino acids (BCAA) lies in the fact that they are increasingly
used in patients with chronic renal failure to supplement low-
protein diets, both for nutritional reasons (maintaining the
nitrogen balance) and in an attempt to slow down progression of
the kidney disease [8—10]. The present study was undertaken to
investigate the effect of three essential amino acids (L-valine,
L-leucine, L-isoleucine) on renal hemodynamics. The results
demonstrated that BCAA have a lesser stimulatory effect on
GFR than a mixture of EAA and nonessential amino acids
(NEAA).
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Methods
Study design
Five, healthy male volunteers aged 19 to 22 years were
submitted to three protocols on different days. Written in-
formed consent was obtained from all the subjects. Their
average protein intake was 80 to 90 g/day on the seven days
preceding the study. On the day of the experiment they were
fasted.
Protocol A
GFR and RPF were measured respectively by the clearance
of polyfructosan S (mutest R, Laevosan-Gesellschaft, Linz,
Austria) and p-aminohippuric acid (PAH, Monico, Italy). A
loading dose of these substances was followed by a constant
infusion at rates calculated for the subject's body weight, to
reach approximately steady-state concentrations of 20 mg/dl for
mutest and 2 mg/dl for PAH. During an equilibration period of
one hour the subjects were given oral water (20 ml/kg body wt)
and an intravenous 0.45% saline infusion (about 500 mllhr) to
induce abundant diuresis. Urine losses were replaced through
the study period by corresponding volumes of water and by
constant infusion of 0.45% saline (500 ml/hr). After the one hour
equilibration period, three blood samples were drawn at five
minute intervals, and a 20-minute urine sample was collected by
spontaneous voiding for one clearance period. BCAA infusion
(Boehringer 4%) was then started at the rate of 8.3 mlfminll .73
m2 body surface area (about 350 mg/min/! .73 m2) and was
continued for three hours. During the last 20 minutes of each
hour urine was collected and two blood samples drawn. Serum
and urinary mutest, PAH, electrolytes, and osmolality as well
as hematocrit (Hct), glycemia, BUN and plasma renin activity
(PRA) were measured. Blood pressure and heart rate were
measured at the start and at the end of the study.
Protocol B
This study was like Protocol A until the end of the equilibra-
tion period when a mixture of NEAA and EAA (Aminocom-
plesso Marxer 3.5%, Pierrel) was infused at the same rate and
for the same time as the BCAA solution. The two amino acid
solutions are compared in the Appendix. The same parameters
were studied as in Protocol A.
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Table 1. Effects of 0.9% saline infusion on giomerular hemodynamics
Baseline
Hour of infusion
1st 2nd 3rd
RPF
ml/min/L73m2
GFR
mi/mini! .73 n2
FF
619
(146)
118
(26)
0.19
(0,014)
586
(174)
105
(28)
0.17
(0.01)a
707
(196)
110
(21)
0.16
(0.01)a
699
(199)
116
(24)
0.17
(0.02r
Table lists mean values (SD).
a P < 0.01 vs. baseline
Protocol C
This study was also like Protocol A until the end of the
equilibration period when the subjects were infused with 0.9%
saline at 8.3 mIIminIl .73 m2 body surface area for three hours.
The parameters studied were the same as in Protocols A and B.
Analytical methods and calculations
Plasma and urinary mutest were determined as described by
Heyrowsky [11] and PAH as described by Brun [12]. PRA was
measured by RIA (Maia Kits, Biodata, Italy). For PRA angio-
tensin I was generated at pH 6. Filtration fraction (FF) was
given by GFRJRPF.
Statistical analysis
The results were submitted to analysis of variance for actual
experiments [13]. Differences between groups were tested by
Tukey's HSD test and differences within groups by Duncan's test.
Data are presented as mean values
To test the variability of the clearance methods used in the
present study we calculated the mean intra-subject coefficient
of variation of basal GFR and RPF in these five subjects. The
coefficients of variation obtained were 5.4 and 8.1% for GFR
and RPF, respectively, demonstrating good reproducibility of
the method and stability of the basal renal hemodynamics of the
subjects.
Results
No modifications of arterial pressure or heart rate or abnor-
mal levels of serum electrolytes, serum osmolality, glycemia or
BUN were observed with any of the three types of infusion.
PRA tended to fall with both the BCAA and the amino acid
mixture infusion, although not significantly (basal was 0.7 2.7
nglmllhr, 3rd hr was 0.35 0.26 ng/mllhr for BCAA; basal was
1.8 1.6 nglml/hr, 3rd hr was 0.86 1.26 nglmllhr for amino
acid mixture), whereas it was suppressed with 0.9% saline
infusion (basal was 1.9 1.35, 3rd hr was 0.52 0.56 nglml/hr,
P < 0.05).
No renal hemodynamic alterations of note, except for a fall in
the FF, were observed when the subjects were given an 0.9%
saline infusion (Table 1).
With the BCAA infusion RPF remained stable in the first
hour of infusion; it then tended to fall at the second hour and
was significantly reduced at the third. With amino acid mixture
there was already an increase at one hour which was maintained
for the following two hours (Table 2). There was an increase in
Table 2. Effects of infusion of branched chain amino acids (BCAA)
and a mixture of NEAA and EAA (AA mix) on glomerular
hemodynamics
Baseline
Hour of infusion
1st 2nd 3rd
RPF mi/mi! .73 m2
BCAA 561
(94)
566
(61)
537
(85)
496
(78)
AAmix 550
(131)
631
(116)
712
(90)b.C
702
(83)b.d
GFR mi/mi! .73m2
BCAA 111
(18)
123(l5) 122(l7) 122(22)
AAmix 114
(17)
137(18 154(25)b.d 148(15)b.C
FF
BCAA 0.2
(0.03)
0.22
(0.02)a
0.23
(003)b
0.25
(003)b
AAmix 0.21
(0.03)
0.21
(0.03)
0.22
(0.03)
0.21
(0.03)C
Table lists mean values (SD).
a p < 0.05 vs. basline
b P < 0.01 vs. baselinep < 0.05 vs. BCAAd p < 0.01 vs. BCAA
GFR with both the amino acid infusions; however, it was
smaller in the case of the BCAA with which a progressive and
significant increase of the FF was also observed. This parame-
ter was, on the contrary, not altered with the amino acid
mixture (Table 2). The percentage variations of GFR and RPF
induced by the BCAA and the amino acid mixture during the
three hours of the test in each subject are shown in Figure 1.
During the BCAA infusion RPF tended to fall in all cases with
a reduction of 10 to 15% at the end of the test; on the contrary,
with the amino acid mixture an increase of RPF occurred that
was 10% in subject 2 and between 40 to 60% in the other
subjects. The GFR percentage increase with BCAA infusion
was never over 15%, whereas with the amino acid mixture it
was 25% in subjects 2 and 5, and between 40 to 60% in the
others.
Discussion
Two amino acid solutions of identical volume, osmolality,
total amino acid and nitrogen content, one consisting of BCAA
and the other of a mixture of NEAA and EAA, were adminis-
tered to the same subjects, and opposite effects on glomerular
hemodynamics were obtained. With the BCAA infusion there
was a tendency for the RPF to decrease, which became
significant at three hours, and only a slight increase of GFR with
a progressive fall of FF. The mixture of NEAA and EAA
instead caused parallel increases of RPF and GFR without
variations of FF.
The evaluation of RPF in our experiment needs a comment.
It is known that organic anions, and among them aromatic
amino acids, exert a competitive inhibition on PAH secretion
[14]. To our knowledge there is no data indicating that neutral
amino acids, such as BCAA, have the same effect. This seems
unlikely because of the high specificity of the transport systems
of all these compounds. Therefore, even if PAH clearance
should be evaluated with caution, an interference with PAH
Subject, number
Fig. 5.Percentage variations with respect to basal values of RPF (LRPF %) and GFR (GFR %) during three hour infusions of branched chain
amino acids ( ) and a mixture of NEAA and EAA ( ) in the 5 subjects.
secretion is more likely to occur when an amino acid mixture,
containing anionic amino acids, is used rather than with BCAA.
To test the influence of volume expansion, osmolar load and
PRA suppression on renal function the subjects were given an
infusion of 0.9% saline. This did not result in glomerular
hemodynamic variations of note except that the FF fell, prob-
ably due to a reduction of the efferent arteriolar resistances as
observed in the course of volume expansion [15].
The two amino acid solutions thus had specific and different
effects on the renal vascular resistances, as was also indicated
by the different behavior of the FF. The BCAA infusion
produced a progressive increase of the FF that may be ex-
plained by an increase of the efferent arteriolar resistances, with
a consequent tendency to renal vasoconstriction and a slight
rise in GFR. This increase of the efferent resistances occurred
without a rise in PRA. Instead the amino acid mixture which did
not cause changes of the FF reduced the arteriolar resistances,
particularly the afferent ones, inducing a flow-dependent in-
crease of GFR.
The mechanisms underlying the hyperfiltration induced by
amino acids are little understood. It has been suggested that it
is mediated by hormones such as OH [16] and glucagon [171 or
by other renal vasodilating humoral factors inhibited by soma-
tostatin [18]. On the other hand, however, recent studies
suggest that the renal hemodynamic modifications induced by
amino acids are related to their intrarenal transport and metab-
olism [19, 20]. Baines, Ho and James [19] demonstrated that in
the isolated perfused kidney of the rat amino acids act
synergetically with piruvate, lactate and glucose to increase
GFR and proximal sodium reabsorption. In the same experi-
mental model Brezis, Silva and Epstein [20] have shown that
some amino acids such as glutamine, glycine and proline,
known to be extracted by the kidney in vivo [21], cause renal
vasodilation associated with increased oxygen consumption,
whereas it is caused only by elevated doses of others (glutamic
acid, alanine, serine). Amino acids cotransported with sodium
but not metabolized by the kidney (taurine, cycloleucine) do not
alter RPF, These authors conclude that the kidney's capacity to
oxidize certain amino acids is related to a fall of renal vascular
resistances.
Our data do not permit us to pinpoint the reason why BCAA
have a lesser stimulatory effect on GFR than a mixture of EAA
and NEAA. Studies have been performed showing that the
administration of BCAA, like that a mixture of EAA and
NEAA, stimulates insulin, glucagon, GH and somatostatin
[22—24]. Thus it seems unlikely that these hormones could be
involved in the observed different renal response to BCAA.
BCAA are reabsorbed in the proximal tubule with a transport
system common to all the neutral amino acids [25]. Therefore
the tubular handling of BCAA does not seem to account for
their different effect on renal hemodynamics. Differences be-
tween BCAA and other amino acids can be found, instead, in
their renal metabolism. in man there is no significant renal
uptake of BCAA in the post-absorptive state [21, 26]. In
addition the specific activity of human renal branched-chain
dehydrogenase is low [27], contrary to what occurs in other
species [27, 28]. Therefore the different effect exerted by BCAA
on GFR and RPF could be consistent with their different renal
metabolic utilization compared with other amino acids con-
tained in the mixture we used (for example, proline and glycine,
which, according to Brezis et al [201, have a more marked renal
vasodilating effect). Clearly, further studies are needed to
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investigate the relation between the intrarenal amino acid
metabolism and the modifications of renal function.
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Appendix 1. Characterist ics of the amipo acid solutions used
Branched-chain Mixture of
amino acids NEAA + EAA
Osmolality mOsm/kg 320 335
Nitrogen concentration 4.5 4.4
giliter
Amino acid concentration 40 35
giliter
Amino acid content glliter
L-valine 12 2.2
L-leucine 15.7 3.6
L-isoleucine 12.9 1.8
L-phenylalanine — 2.5
L-methionine — 1.5
L-lysine — 3.0
L-threonine — 1.3
L-tryptophan — 0.5
L-aspartic acid — 2.0
L-glutamic acid — 6.9
L-serine — 1,4
L-proline — 4.3
L-glycine — 2.6
L-alanine — 1.2
L-arginine — 0.7
L-tyrosine — 0.3
L-histidine — 1.0
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